Hemp & CBD Expo Business Pro Seminars: September 2019 Paul Ryan & David Caballero-Lima - (Labskin) How to anticipate regulation and get ahead of the industry
Labskin supporting product claims for CBD cosmetics and personal care products.
Testing CBD on the Human Microbiome
Data Analysis on the Labskin AI platform to support product claims
Paul Ryan
-Chief Business Development Officer
Paul has extensive international experience in software sales, with cross sectoral experience in healthcare, utilities and telecommunications. Paul was most recently Head of New Business Development at 8 West Consulting, an Irish software development company whose 240+ personnel serve healthcare and ecommerce markets, with customers including Avon, Image Skincare, Estee Lauder and Anthem Inc., the Fortune 50 US health insurer. Paul has managed strategic partnering programmes and initiatives with companies such as Siemens, Microsoft, Accenture, Sony and IBM.
David Caballero-Lima
-Senior Scientist Microbiology and R&D Coordinator
David acquired both his undergraduate degree in Biology and PhD in Biomedical Sciences from the Universidad de Extremadura in Spain. After completing his PhD, David took a couple of postdoctoral research positions at the University of Sheffield and the University of Manchester. Both roles focused on studying human pathogens either through the development of a diagnostic device or obtaining a greater understanding in the regulation of vesicle transportation in morphological changes. David’s extensive academic background brings a fresh perspective to the research and development programme at Labskin.
Company Info:
Labskin (a company within the Integumen PLC group) delivers unrivalled human skin microbiology services to support product R&D activities in the cosmetic, personal care, medical device and pharmaceutical sectors.
Labskin has specific expertise in CBD:
2018 – Successfully proved that CBD demonstrated anti-microbial and anti-inflammatory effects in skin-care formulations for group company cosmetic products (Stoer brand).
2019 – Validation of CBD expertise by successfully testing CBD infused female hygiene products for a commercial customer.
2019/20 – Test program for CBD personal products for a commercial customer.
2020 – Pharma grade CBD oil is available via group partner company Cellulac, with whom we are testing CBD effectiveness for wound care.
For rapid, focused analysis or flexible, tailor-made research programmes we develop and validate skin care ingredients and products. Our skin model is a 3D human skin equivalent that incorporates vital biological components to model normal skin function. Our customers include Boots, L'Oreal, L'Occitane and other global brands.
0 Comments